142 related articles for article (PubMed ID: 26066373)
1. BRAF V600E mutations: a series of case reports in patients with non-small cell lung cancer.
Goldman JM; Gray JE
Cancer Genet; 2015 Jun; 208(6):351-4. PubMed ID: 26066373
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of BRAF gene mutations in patients with non-small cell lung cancer.
Kobayashi M; Sonobe M; Takahashi T; Yoshizawa A; Ishikawa M; Kikuchi R; Okubo K; Huang CL; Date H
Anticancer Res; 2011 Dec; 31(12):4619-23. PubMed ID: 22199339
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and outcome of patients with lung cancer harboring BRAF mutations.
Tissot C; Couraud S; Tanguy R; Bringuier PP; Girard N; Souquet PJ
Lung Cancer; 2016 Jan; 91():23-8. PubMed ID: 26711930
[TBL] [Abstract][Full Text] [Related]
4. BRAF-mutations in non-small cell lung cancer.
Brustugun OT; Khattak AM; Trømborg AK; Beigi M; Beiske K; Lund-Iversen M; Helland Å
Lung Cancer; 2014 Apr; 84(1):36-8. PubMed ID: 24552757
[TBL] [Abstract][Full Text] [Related]
5. Natural Disease History, Outcomes, and Co-mutations in a Series of Patients With BRAF-Mutated Non-small-cell Lung Cancer.
Myall NJ; Henry S; Wood D; Neal JW; Han SS; Padda SK; Wakelee HA
Clin Lung Cancer; 2019 Mar; 20(2):e208-e217. PubMed ID: 30442523
[TBL] [Abstract][Full Text] [Related]
6. The presence of HER2 exon 20 insertion in patients with central nervous system metastases from non-small lung cancer--a potential application in classification for therapy.
Nicoś M; Krawczyk P; Mlak R; Sawicki M; Jarosz B; Powrózek T; Milanowski P; Trojanowski T; Milanowski J
Pneumonol Alergol Pol; 2013; 81(4):294-7. PubMed ID: 23744164
[TBL] [Abstract][Full Text] [Related]
7. Clinical features and outcome of patients with non-small-cell lung cancer harboring BRAF mutations.
Marchetti A; Felicioni L; Malatesta S; Grazia Sciarrotta M; Guetti L; Chella A; Viola P; Pullara C; Mucilli F; Buttitta F
J Clin Oncol; 2011 Sep; 29(26):3574-9. PubMed ID: 21825258
[TBL] [Abstract][Full Text] [Related]
8. The histopathology of BRAF-V600E-mutated lung adenocarcinoma.
Yousem SA; Nikiforova M; Nikiforov Y
Am J Surg Pathol; 2008 Sep; 32(9):1317-21. PubMed ID: 18636014
[TBL] [Abstract][Full Text] [Related]
9. V600E BRAF versus Non-V600E BRAF Mutated Lung Adenocarcinomas: Cytomorphology, Histology, Coexistence of Other Driver Mutations and Patient Characteristics.
Salimian KJ; Fazeli R; Zheng G; Ettinger D; Maleki Z
Acta Cytol; 2018; 62(2):79-84. PubMed ID: 29320776
[TBL] [Abstract][Full Text] [Related]
10. Patients with non-small-cell lung cancer harbouring a
Auliac JB; Bayle S; Vergnenegre A; Le Caer H; Falchero L; Gervais R; Doubre H; Vinas F; Marin B; Chouaid C
Curr Oncol; 2018 Oct; 25(5):e398-e402. PubMed ID: 30464690
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic characteristics and outcomes of Chinese patients with non-small-cell lung cancer and BRAF mutation.
Ding X; Zhang Z; Jiang T; Li X; Zhao C; Su B; Zhou C
Cancer Med; 2017 Mar; 6(3):555-562. PubMed ID: 28135039
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics and course of 63 patients with BRAF mutant lung cancers.
Litvak AM; Paik PK; Woo KM; Sima CS; Hellmann MD; Arcila ME; Ladanyi M; Rudin CM; Kris MG; Riely GJ
J Thorac Oncol; 2014 Nov; 9(11):1669-74. PubMed ID: 25436800
[TBL] [Abstract][Full Text] [Related]
13. Negative reactions of BRAF mutation-specific immunohistochemistry to non-V600E mutations of BRAF.
Seto K; Haneda M; Masago K; Fujita S; Kato S; Sasaki E; Hosoda W; Murakami Y; Kuroda H; Horio Y; Hida T; Okubo K; Yatabe Y
Pathol Int; 2020 May; 70(5):253-261. PubMed ID: 31970865
[TBL] [Abstract][Full Text] [Related]
14. A BRAF new world.
Frisone D; Friedlaender A; Malapelle U; Banna G; Addeo A
Crit Rev Oncol Hematol; 2020 Aug; 152():103008. PubMed ID: 32485528
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Survival of a Patient With Non-Small-Cell Lung Cancer Harboring a V600E Mutation in the BRAF Oncogene.
Myall NJ; Neal JW; Cho-Phan CD; Zhou LY; Stehr H; Zhou L; Diehn M; Wakelee HA
Clin Lung Cancer; 2016 Mar; 17(2):e17-21. PubMed ID: 26776917
[No Abstract] [Full Text] [Related]
16. Does V600E BRAF mutation predict vinorelbine efficacy? A proof-of-concept from a lung micropapillary adenocarcinoma metastatic to the breast.
Carassai P; Jocollé G; Donati G; Spinazzé S; Baiocco C; Baderna P; Martinet A; Lococo F; Migliaccio F; Rossi G
Pathologica; 2017 Dec; 109(4):426-428. PubMed ID: 29449740
[No Abstract] [Full Text] [Related]
17. A rare case of squamous cell carcinoma of the lung harbouring ALK and BRAF activating mutations.
Alrifai D; Popat S; Ahmed M; Gonzalez D; Nicholson AG; Parcq Jd; Benepal T
Lung Cancer; 2013 Jun; 80(3):339-40. PubMed ID: 23499398
[TBL] [Abstract][Full Text] [Related]
18. BRAF V600E Mutations in Endometrial Adenocarcinoma.
He M; Breese V; Hang S; Zhang C; Xiong J; Jackson C
Diagn Mol Pathol; 2013 Mar; 22(1):35-40. PubMed ID: 23370429
[TBL] [Abstract][Full Text] [Related]
19. No evidence for BRAF-V600E mutations in gastroeosophageal tumors: results from a high-throughput analysis of 534 cases using a mutation-specific antibody.
Preusser M; Berghoff AS; Capper D; von Deimling A; Maroske F; Brodowicz T; Hejna M; Birner P; Schoppmann SF
Appl Immunohistochem Mol Morphol; 2013 Oct; 21(5):426-30. PubMed ID: 23343956
[TBL] [Abstract][Full Text] [Related]
20. BRAF
Rosell R; Karachaliou N
Lancet Oncol; 2017 Oct; 18(10):1286-1287. PubMed ID: 28919012
[No Abstract] [Full Text] [Related]
[Next] [New Search]
